PharMerica's Fall Risk Toolkit

According to the CDC, more than 1 in 4 older adults fall annually. The effects of a fall, even one that does not cause serious injuries, can have a significant impact on a senior’s life and lead to a decline in health and well-being. Our updated Fall Risk Toolkit takes a deep dive into the causes of falls, how your pharmacist can help mitigate medication-related risks, and the steps your community can take to evaluate risk and prevent life-altering falls.

Reducing Staff Burden in Senior Living Communities: Practical Strategies

Senior living communities nationwide are facing the same challenge: how to provide high-quality quality care while dealing with staffing shortages, rising acuity, and increasing regulatory requirements. Learn practical strategies your community can use to help relieve burden on staff, increase retention, and maintain quality of care.

Did You Know: Insulin Pens vs. Vials — Clinical Considerations

Insulin is a high-risk medication available in both vial and pen dosage forms. Improper preparation or administration can contribute to safety concerns, poor glycemic control, infection transmission, and other adverse outcomes. When choosing between pens and vials, facilities must balance cost, safety, nursing efficiency, medication waste, and resident satisfaction. 

Did You Know: Safe Disposal of Fentanyl Transdermal Patches

A substantial amount of fentanyl remains in a transdermal patch even after use, creating a risk for abuse, misuse, diversion, and accidental exposure. Because fentanyl is an extremely potent opioid with multiple boxed warnings, accidental exposure or ingestion can result in serious injury or death. Facilities must dispose of fentanyl patches using a method which renders any remaining drug inaccessible and non-retrievable.

Understanding the New Long Stay Antipsychotic Quality Measure, Part 2: Compliance, Operational, & Regulatory Requirements

September 15, 2026

1:00 pm ET

This program will cover the clinical, operational, and regulatory changes in the March 2026 update to Quality Measure #N047.01, including documentation, MDS coding, compliance, and new responsibilities for the IDT. Attendees will gain clarity on the roles of medical directors, prescribers, clinical leaders, pharmacists, and consultant pharmacists in developing policies, educating staff, and ensuring compliance.

Psychotropic Medication Support in the I/DD Population

September 22, 2026

1:00 pm ET

This webinar will outline a clinical oversight framework for the safe, ethical, and person-centered use of psychotropic medications among individuals with intellectual and developmental disabilities (I/DD). It will address high-risk prescribing, informed consent, human rights, and practical strategies to support medication safety, consistent care, and improved quality-of-life outcomes.